SEC FORM 4

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROSE WILLIAM

(Last)

(First)

(Middle)

4215 WEST LOVERS LANE, SUITE 200

(Street)

DALLAS

75209

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
REATA PHARMACEUTICALS INC [ RETA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽¹⁾			29,000	⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	1,848,998	I	By Trust⁽⁶⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽²⁾			29,000	⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	1,819,998	I	By Trust⁽⁶⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽³⁾			29,000	⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	1,790,998	I	By Trust⁽⁶⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽³⁾	V	29,000		⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	29,000	I	By Trust⁽⁷⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽⁴⁾			29,000	⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	1,761,998	I	By Trust⁽⁶⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽⁴⁾	V	29,000		⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	29,215	I	By Trust⁽⁸⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽⁵⁾			29,000	⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	1,732,998	I	By Trust⁽⁶⁾
Class B Common Stock	⁽¹³⁾	09/15/2023		G⁽⁵⁾	V	29,000		⁽¹³⁾	⁽¹³⁾	Class A common stock	29,000	$0.00	29,492	I	By Trust⁽⁹⁾
Class B Common Stock	⁽¹³⁾							⁽¹³⁾	⁽¹³⁾	Class A common stock	129,308		129,308	D⁽¹⁰⁾
Class B Common Stock	⁽¹³⁾							⁽¹³⁾	⁽¹³⁾	Class A common stock	87,776		87,776	I	See Footnote⁽¹¹⁾
Class B Common Stock	⁽¹³⁾							⁽¹³⁾	⁽¹³⁾	Class A common stock	313		313	I	See Footnote⁽¹²⁾

Explanation of Responses:

1. This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family trust.

2. This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family trust.

3. This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the Edward Alexander Rose 1999 Trust, for which William E. Rose serves as co-trustee.

4. This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the Charles Henry Rose 2001 Trust.

5. This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the John William Rose 2002 Trust.

6. These shares are owned directly by the Evelyn Potter Rose Survivor's Trust, for which Charles E. Gale and Evelyn P. Rose serve as co-trustees.

7. These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the Edward Alexander Rose 1999 Trust.

8. These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the Charles Henry Rose 2001 Trust.

9. These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the John William Rose 2002 Trust.

10. These shares are owned directly by William E. Rose, a director of the Issuer.

11. These shares are owned directly by the Evelyn P. Rose Fidelity SEP IRA and indirectly by Evelyn R. Rose.

12. These shares are owned directly by the Charles E. Gale Fidelity Rollover IRA and indirectly by Charles E. Gale.

13. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.

Remarks:

	/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose	09/19/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.